Search - tctmd.com

Displaying 1 - 20 of 45

Sort: Relevancy | Date

News Conference News CX Symposium 2025

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

L.A. McKeown

April 30, 2025

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

L.A. McKeown

April 24, 2025

News Daily News

Survey Calls Out Implicit Bias in Peripheral Vascular Care

L.A. McKeown

February 28, 2025

News Conference News VIVA 2024

Advocates Urge Heat Maps and Grassroots Campaigns to Improve PAD Care

L.A. McKeown

November 07, 2024

News Daily News

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

L.A. McKeown

June 18, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Daily News

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

L.A. McKeown

March 25, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

News Daily News

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

L.A. McKeown

July 11, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Daily News

AHA Scientific Statement Addresses Health Disparities in PAD

L.A. McKeown

June 23, 2023

News Conference News LINC 2023

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

L.A. McKeown

June 21, 2023

News Conference News SCAI 2023

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

L.A. McKeown

May 25, 2023

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Conference News VIVA 2022

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

L.A. McKeown

November 04, 2022

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

L.A. McKeown

June 01, 2022

Advertisement

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

Survey Calls Out Implicit Bias in Peripheral Vascular Care

Advocates Urge Heat Maps and Grassroots Campaigns to Improve PAD Care

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

May 2024 Dispatch for the CV Team

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

March 2024 Dispatch for the CV Team

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

September 2023 News Roundup

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

AHA Scientific Statement Addresses Health Disparities in PAD

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

September 2022 News Roundup

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content